TEVA 149 Pill — RED OVAL, 16mm — Naproxen

TEVA pill photo
View full Naproxen profile
ImprintTEVA / 149
ColourRED
ShapeOVAL
Size16
StrengthNAPROXEN 500 mg
Dosage formTablet
ManufacturerClinical Solutions Wholesale, LLC
NDC58118-0149
Schedule—
Availability—
IngredientsNAPROXEN[NAPROXEN]

What does this imprint mean?

The imprint "TEVA 149" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Naproxen

Uses and warnings

BOXED WARNING: Boxed Warning - Cardiovascular & GI Risk: NSAIDs increase risk of serious cardiovascular thrombotic events (myocardial infarction, stroke) that can be fatal, potentially early in treatment. They also cause increased risk of serious gastrointestinal bleeding, ulceration, and perforation, which can occur without warning symptoms. Key Warnings Include: - Contraindicated after coronary artery bypass graft surgery - "Patients with a prior history of peptic ulcer disease...had a greater than 10-fold increased risk for developing a GI bleed" - Risk of hepatotoxicity, hypertension, heart failure, renal toxicity, anaphylactic reactions, serious skin reactions, and hematologic toxicity - Avoid in pregnant women starting at 30 weeks gestation due to fetal ductus arteriosus closure risk

Naproxen sodium tablets treat rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and juvenile arthritis. They also relieve tendonitis, bursitis, acute gout, pain, and primary dysmenorrhea. "Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals."

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Naproxen

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 520615e0-6414-0915-e054-00144ff8d46c.xml